Chikungunya vaccine

Caitlin Soto, PharmD, BCIDP

VACCINE TYPE

  • A virus-like particle (VLP) vaccine (VIMKUNYA™) that contains purified VLPs consisting of CHIKV capsid protein (C) and envelope proteins E1 and E2, derived from the CHIKV Senegal strain 37997
    • Available for individuals 12 years of age and older

*See Other Information under Indications for important safety information regarding the FDA suspension for IXCHIQ [8/2025]

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.